Copyright
©The Author(s) 2023.
World J Diabetes. Jun 15, 2023; 14(6): 656-679
Published online Jun 15, 2023. doi: 10.4239/wjd.v14.i6.656
Published online Jun 15, 2023. doi: 10.4239/wjd.v14.i6.656
Mechanism/pathway (diabetes type) | Expression of miRNAs | Ref. |
Endothelial dysfunction (T2DM) | ↑miR-28-3p | [87] |
↓miR-24 | ||
↓miR-21 | ||
↓miR-20b | ||
↓miR-15a | ||
↓miR-126 | ||
↓miR-191 | ||
↓miR-197 | ||
↓miR-223 | ||
↓miR-320 | ||
↓miR-486 | ||
↓miR-150 | ||
↓miR-29b | ||
↓miR-107 | ||
↓miR-132 | ||
↓miR-144 | ||
Glucose metabolism (T2DM) | ↑miR-9 | [88] |
↑miR-29a | ||
↑miR-30d | ||
↑miR-34a | ||
↑miR-124a | ||
↑miR-146a | ||
↑miR-375 | ||
Inflammation (T2DM) | ↓miR-146a | [89] |
Glucose metabolism (T2DM) | ↑miR-27a | [90] |
↑miR-320a | ||
Glucose metabolism (T2DM) | ↓miR-126 | [91-93] |
Inflammation (T2DM) | ↓miR-103b | [94] |
Inflammation (T2DM) | ↓miR-126-3p | [95] |
↓miR-21-5p | ||
Inflammation (T2DM) | ↓miR-126 | [96] |
Endothelial dysfunction (T2DM) | ↓miR-126 | [97] |
↓miR-26a | ||
Glucose metabolism (T2DM) | ↓miR-21 | [98] |
Inflammation (T2DM) | ↓miR-126-3p | [99] |
Endothelial dysfunction (T2DM) | ↓miR-24 | [100] |
Platelet reactivity (T2DM) | ↓miR-223 | [101] |
↓miR-26b | ||
↓miR-126 | ||
↓miR-140 | ||
Glucose metabolism (T2DM) | ↑miR-375 | [102] |
↑miR-9 | ||
Glucose metabolism (T2DM) | ↑miR-30a-5p | [103] |
↑miR-150 | ||
↓miR-103 | ||
↓miR-28-3p | ||
↓miR-29a | ||
↓miR-9 | ||
↓miR-15a | ||
↓miR-126 | ||
↓miR-145 | ||
↓miR-375 | ||
↓miR-223 | ||
↓miR-133 | ||
↓miR-107 | ||
Endothelial dysfunction (miR-126); hypoxia (miR-210) (T2DM) | ↓miR-126 | [104] |
↑miR-210 | ||
Angiogenesis (T2DM) | ↑miR-193b-3p | [105] |
↑let-7i-5p | ||
↑miR-199a-3-5p | ||
↑miR-26b-5p | ||
↑miR-30b-5p | ||
↑miR-374a-5p | ||
↑miR-20a-3p | ||
↑miR-26a-5p | ||
↑miR-30c-5p | ||
↓miR-409-3p | ||
↓miR-95-3p | ||
Apoptosis (T1DM) | ↑miR-21 | [106,107] |
↓miR-23a-3p | [108] | |
↓miR-23b-3p | ||
↓miR-149-5p | ||
Inflammation (T1DM) | ↑miR-101a | [109] |
↑miR-30b | ||
-cell dysfunction (T1DM) | ↑miR-106b-5p | [110,111] |
↑miR-222-3p | ||
↑miR-181a | ||
T-cell dysfunction (T1DM) | ↑miR-26a | [112] |
↑miR-98 | [113] | |
↑miR-23b | ||
↑miR-590-5p | ||
-cell lymphopoiesis (T1DM) | ↑miR-34a | [114] |
DNA damage checkpoint (T1DM) | ↑miR-200 | [115] |
Apoptosis (T1DM) | ↓miR-144 | [116] |
Autoimmune imbalance (T1DM) | ↓miR-146a | [117] |
MODY | ↑miR-103 | [118] |
MODY | ↑miR-224 | |
Glucose metabolism (GDM) | ↑miR-222 | [119] |
↑miR-98 | [120] | |
↑miR-518d | [121] | |
↑miR-340 | [122] | |
↑miR-130b, miR148a | [123] | |
-cell dysfunction (GDM) | ↑miR-33a-5p | [124] |
↑miR-330-3p | [125] | |
↓miR-494 | [126] | |
↓miR-96 | [127] | |
↓miR-221 | [128] |
- Citation: Goyal S, Rani J, Bhat MA, Vanita V. Genetics of diabetes. World J Diabetes 2023; 14(6): 656-679
- URL: https://www.wjgnet.com/1948-9358/full/v14/i6/656.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i6.656